Ann Lee-Karlon

Ann Lee-Karlon is a highly accomplished individual who excels in lead portfolio management and operations within the drug development sector at Genentech, supervising numerous development teams.

With a strong background in bioengineering and business, Ann has held various key roles in Genentech, including Senior Vice President, Vice President, and Project Team Leader.

Ann Lee-Karlon is deeply involved in the tech and startup scene, serving on the board of Eko, a company specializing in AI-driven insights and advanced stethoscopes.

Ann's dedication to education and engineering is evident through her involvement as a board member in UC Berkeley's and UC San Diego's engineering advisory boards.

Having completed a Postdoctoral Fellowship at University College London and earning a PhD in Bioengineering from UC San Diego, Ann is well-versed in the field.

She has also been recognized for her leadership and contributions, being honored by the UC President's Office as one of the Remarkable Women of the University of California.

Additionally, Ann Lee-Karlon has a strong commitment to philanthropy, having served as the President and Board Chair of the Genentech Patient Foundation and a Genentech Diversity and Inclusion Board Member.

As a Fellow of the Aspen Institute and the American Institute for Medical and Biological Engineering, Ann's expertise and influence extend beyond the corporate world into prestigious organizations.